|
NL154598B
(nl)
|
1970-11-10 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
|
|
US3817837A
(en)
|
1971-05-14 |
1974-06-18 |
Syva Corp |
Enzyme amplification assay
|
|
US3939350A
(en)
|
1974-04-29 |
1976-02-17 |
Board Of Trustees Of The Leland Stanford Junior University |
Fluorescent immunoassay employing total reflection for activation
|
|
US3996345A
(en)
|
1974-08-12 |
1976-12-07 |
Syva Company |
Fluorescence quenching with immunological pairs in immunoassays
|
|
US4277437A
(en)
|
1978-04-05 |
1981-07-07 |
Syva Company |
Kit for carrying out chemically induced fluorescence immunoassay
|
|
US4275149A
(en)
|
1978-11-24 |
1981-06-23 |
Syva Company |
Macromolecular environment control in specific receptor assays
|
|
US4366241A
(en)
|
1980-08-07 |
1982-12-28 |
Syva Company |
Concentrating zone method in heterogeneous immunoassays
|
|
US4447233A
(en)
|
1981-04-10 |
1984-05-08 |
Parker-Hannifin Corporation |
Medication infusion pump
|
|
US4439196A
(en)
|
1982-03-18 |
1984-03-27 |
Merck & Co., Inc. |
Osmotic drug delivery system
|
|
US4447224A
(en)
|
1982-09-20 |
1984-05-08 |
Infusaid Corporation |
Variable flow implantable infusion apparatus
|
|
US4487603A
(en)
|
1982-11-26 |
1984-12-11 |
Cordis Corporation |
Implantable microinfusion pump system
|
|
US4543439A
(en)
*
|
1982-12-13 |
1985-09-24 |
Massachusetts Institute Of Technology |
Production and use of monoclonal antibodies to phosphotyrosine-containing proteins
|
|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
|
US5534617A
(en)
|
1988-10-28 |
1996-07-09 |
Genentech, Inc. |
Human growth hormone variants having greater affinity for human growth hormone receptor at site 1
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5977307A
(en)
*
|
1989-09-07 |
1999-11-02 |
Alkermes, Inc. |
Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins
|
|
CA2025907A1
(en)
|
1989-09-21 |
1991-03-22 |
Franklin D. Collins |
Method of transporting compositions across the blood brain barrier
|
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
CA2078689C
(en)
|
1990-03-20 |
2003-02-11 |
Sherie L. Morrison |
Chimeric antibodies with receptor binding ligands in place of their constant region
|
|
CA2058041A1
(en)
|
1990-06-27 |
1991-12-28 |
Katsuichi Sakano |
Anti-igf-ii monoclonal antibody
|
|
US6300129B1
(en)
*
|
1990-08-29 |
2001-10-09 |
Genpharm International |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5198340A
(en)
*
|
1991-01-17 |
1993-03-30 |
Genentech, Inc. |
Assay for free igf-i, igf-ii, and gh levels in body fluids
|
|
US5262308A
(en)
*
|
1992-01-28 |
1993-11-16 |
Thomas Jefferson University |
Cell lines which constitutively express IGF-1 and IGF-1 R
|
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
JPH07509250A
(ja)
*
|
1992-07-27 |
1995-10-12 |
アメリカ合衆国 |
血液脳バリヤーへのリポソームの標的化
|
|
JPH08508409A
(ja)
*
|
1993-04-06 |
1996-09-10 |
シーダーズ − サイナイ メディカル センター |
変異インスリン様増殖因子▲i▼受容体サブユニットおよびそれらの使用方法
|
|
US20020022023A1
(en)
*
|
1999-01-15 |
2002-02-21 |
Axel Ullrich |
Treatment of diabetes mellitus and insulin receptor signal transduction
|
|
AUPM672594A0
(en)
|
1994-07-08 |
1994-08-04 |
Royal Children's Hospital Research Foundation |
A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders
|
|
WO1997018241A1
(en)
*
|
1995-11-14 |
1997-05-22 |
Thomas Jefferson University |
Inducing resistance to tumor growth with soluble igf-1 receptor
|
|
US6346390B1
(en)
*
|
1996-03-08 |
2002-02-12 |
Receptron, Inc. |
Receptor derived peptides involved in modulation of response to ligand binding
|
|
US5958872A
(en)
*
|
1996-04-01 |
1999-09-28 |
Apoptosis Technology, Inc. |
Active survival domains of IGF-IR and methods of use
|
|
US20020187925A1
(en)
*
|
1996-05-22 |
2002-12-12 |
Kingston David J. |
Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof
|
|
AUPN999096A0
(en)
|
1996-05-22 |
1996-06-13 |
Northstar Biologicals Pty Ltd |
Peptides, antibodies, vaccines & uses thereof
|
|
US20020155095A1
(en)
*
|
1996-10-18 |
2002-10-24 |
Tattanahalli L. Nagabhushan |
Methods and compositions for delivery and expression of interferon-a nucleic acids
|
|
BR9712362A
(pt)
|
1996-10-18 |
1999-08-31 |
Canji Inc |
Métodos e composições para distribuição e expressão de ácidos nucléicos de alfa-interferon
|
|
WO1998022092A1
(en)
|
1996-11-22 |
1998-05-28 |
The Regents Of The University Of California |
Transport of liposomes across the blood-brain barrier
|
|
US6294330B1
(en)
*
|
1997-01-31 |
2001-09-25 |
Odyssey Pharmaceuticals Inc. |
Protein fragment complementation assays for the detection of biological or drug interactions
|
|
US6121416A
(en)
|
1997-04-04 |
2000-09-19 |
Genentech, Inc. |
Insulin-like growth factor agonist molecules
|
|
DE19719001C2
(de)
|
1997-05-06 |
2001-05-10 |
Schuetzdeller Angelika |
Verfahren zum immunologisch-funktionalen Nachweis biologisch aktiver Insulin-Like Growth Factor Binding Proteine oder löslicher Insulin-Like Growth Factor - Rezeptoren im Immunoassay
|
|
KR20010015817A
(ko)
|
1997-11-14 |
2001-02-26 |
유로-셀티큐 에스.에이. |
항-이디오타입 반응을 유도하는 능력이 강화된 변형된 항체
|
|
EP1034188B1
(en)
|
1997-11-27 |
2006-06-07 |
Commonwealth Scientific And Industrial Research Organisation |
Method of designing agonists and antagonists to igf receptor (1-462)
|
|
CA2322200A1
(en)
|
1998-02-24 |
1999-08-26 |
Receptron, Inc. |
Receptor derived peptides as modulators of receptor activity
|
|
ZA200007412B
(en)
*
|
1998-05-15 |
2002-03-12 |
Imclone Systems Inc |
Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases.
|
|
AU4079999A
(en)
|
1998-05-15 |
1999-12-06 |
Imclone Systems Incorporated |
Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases
|
|
GB9818110D0
(en)
|
1998-08-19 |
1998-10-14 |
Weston Medical Ltd |
Needleless injectors and other devices
|
|
US20030236190A1
(en)
*
|
1998-09-02 |
2003-12-25 |
Renuka Pillutla |
Isulin and IGF-1 receptor agonists and antagonists
|
|
US7173005B2
(en)
*
|
1998-09-02 |
2007-02-06 |
Antyra Inc. |
Insulin and IGF-1 receptor agonists and antagonists
|
|
US6875741B2
(en)
*
|
1998-09-02 |
2005-04-05 |
Renuka Pillutla |
Insulin and IGF-1 receptor agonists and antagonists
|
|
EP1953229A3
(en)
|
1998-10-15 |
2008-12-24 |
Novartis Vaccines and Diagnostics, Inc. |
Metastatic breast and colon cancer regulated genes
|
|
US6096002A
(en)
|
1998-11-18 |
2000-08-01 |
Bioject, Inc. |
NGAS powered self-resetting needle-less hypodermic jet injection apparatus and method
|
|
WO2000050067A1
(en)
|
1999-02-26 |
2000-08-31 |
Saltech I Göteborg Ab |
Method and composition for the regulation of hepatic and extrahepatic production of insulin-like growth factor-1
|
|
US6316462B1
(en)
*
|
1999-04-09 |
2001-11-13 |
Schering Corporation |
Methods of inducing cancer cell death and tumor regression
|
|
WO2000069454A1
(en)
|
1999-05-17 |
2000-11-23 |
Board Of Regents, The University Of Texas System |
Suppression of endogenous igfbp-2 to inhibit cancer
|
|
AU6607100A
(en)
|
1999-07-23 |
2001-02-13 |
Regents Of The University Of California, The |
Anti-growth factor receptor avidin fusion proteins as universal vectors for drugdelivery
|
|
AU1339701A
(en)
|
1999-10-22 |
2001-05-08 |
Lifespan Biosciences, Inc. |
Anti-cancer nucleic acid and protein targets
|
|
WO2001036632A2
(en)
|
1999-11-17 |
2001-05-25 |
Compugen Ltd. |
Variants of alternative splicing
|
|
AU2135001A
(en)
*
|
1999-12-15 |
2001-06-25 |
Mcgill University |
Targeting of endosomal growth factor processing as anti-cancer therapy
|
|
WO2001070930A2
(en)
|
2000-03-21 |
2001-09-27 |
University Of South Florida |
Growth factor binding molecules
|
|
JP2003527441A
(ja)
|
2000-03-22 |
2003-09-16 |
グラクソ グループ リミテッド |
細胞周期を阻止する薬剤及び抗体を含む医薬
|
|
TWI310684B
(en)
*
|
2000-03-27 |
2009-06-11 |
Bristol Myers Squibb Co |
Synergistic pharmaceutical kits for treating cancer
|
|
EP2368902A3
(en)
|
2000-03-29 |
2011-12-21 |
DGI Bio Technologies LLC |
Insulin and IGF-1 receptor agonists and antagonists
|
|
EP1268510A4
(en)
|
2000-03-31 |
2003-05-28 |
Hyseq Inc |
METHOD AND MATERIALS RELATING TO POLYPEPTIDES AND POLYNUCLEOTIDES LIKE INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN
|
|
US6372250B1
(en)
*
|
2000-04-25 |
2002-04-16 |
The Regents Of The University Of California |
Non-invasive gene targeting to the brain
|
|
US20030165502A1
(en)
*
|
2000-06-13 |
2003-09-04 |
City Of Hope |
Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth
|
|
US7329745B2
(en)
*
|
2000-06-13 |
2008-02-12 |
City Of Hope |
Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth
|
|
US20020164333A1
(en)
*
|
2000-07-10 |
2002-11-07 |
The Scripps Research Institute |
Bifunctional molecules and vectors complexed therewith for targeted gene delivery
|
|
JP2004502450A
(ja)
|
2000-07-10 |
2004-01-29 |
ノバルティス アクチエンゲゼルシャフト |
ターゲッティング遺伝子送達のための二官能性分子およびそれと複合化されたベクター
|
|
WO2002007783A2
(en)
|
2000-07-20 |
2002-01-31 |
Regents Of The University Of Minnesota |
Radiolabeled immunotoxins
|
|
US20030162230A1
(en)
|
2000-09-27 |
2003-08-28 |
Reagan Kevin J. |
Method for quantifying phosphokinase activity on proteins
|
|
US8153121B2
(en)
*
|
2000-10-06 |
2012-04-10 |
Los Angeles Biomedical Research Institute at Harbor—UCLA Medical Center |
Diagnosis and therapy of antibody-mediated inflammatory autoimmune disorders
|
|
DE10050338A1
(de)
|
2000-10-11 |
2002-04-25 |
Deutsches Krebsforsch |
Auf dem Nachweis von IGF-IRbeta und IRS-1 beruhendes Diagnose- bzw. Klassifizierungsverfahren für Carcinome
|
|
US20030088061A1
(en)
*
|
2000-10-12 |
2003-05-08 |
Staunton Donald E. |
Materials and methods to modulate ligand binding/enzymatic activity of alpha/beta proteins containing an allosteric regulatory site
|
|
EP1332368A2
(en)
*
|
2000-11-03 |
2003-08-06 |
Board of Regents, The University of Texas System |
Methods for detecting the efficacy of anticancer treatments
|
|
AU2002225756A1
(en)
|
2000-12-01 |
2002-06-11 |
Schering Corporation |
Uses of mammalian genes and related reagents
|
|
WO2002054066A2
(en)
|
2000-12-14 |
2002-07-11 |
The Burnham Institute |
Non-apoptotic forms of cell death and methods of modulation
|
|
ES2344592T3
(es)
*
|
2001-01-05 |
2010-09-01 |
Pfizer Inc. |
Anticuerpos frente al receptor del factor de crecimiento similar a la insulina i.
|
|
ES2330201T3
(es)
*
|
2001-01-26 |
2009-12-07 |
Selexis S.A. |
Regiones de union a la matriz y metodos para el uso de las mismas.
|
|
CA2439735A1
(en)
*
|
2001-03-14 |
2002-09-19 |
Genentech, Inc. |
Igf antagonist peptides
|
|
FR2824076B1
(fr)
|
2001-04-27 |
2003-06-13 |
Centre Nat Rech Scient |
Methode de detection de composes activateurs ou inhibiteurs des recepteurs de la famille du recepteur de l'insuline au moyen d'un recepteur chimere isole
|
|
US20040116330A1
(en)
*
|
2001-04-27 |
2004-06-17 |
Kenichiro Naito |
Preventive/therapeutic method for cancer
|
|
AU2002348477A1
(en)
*
|
2001-05-01 |
2002-12-23 |
The General Hospital Corporation |
Photoimmunotherapies for cancer using photosensitizer immunoconjugates and combination therapies
|
|
TWI238824B
(en)
*
|
2001-05-14 |
2005-09-01 |
Novartis Ag |
4-amino-5-phenyl-7-cyclobutyl-pyrrolo[2,3-d]pyrimidine derivatives
|
|
IL159177A0
(en)
|
2001-06-20 |
2004-06-01 |
Prochon Biotech Ltd |
Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
|
|
WO2003000928A2
(en)
|
2001-06-25 |
2003-01-03 |
Buadbo Aps |
Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof
|
|
WO2003014696A2
(en)
|
2001-08-06 |
2003-02-20 |
Stil Biotechnologies Ltd. |
Methods of identifying functional analogs of peptide regulators of biological pathways
|
|
AUPR870501A0
(en)
|
2001-11-07 |
2001-11-29 |
Biotech Research Ventures Pte Limited |
Composition containing a flavonoid glycone and method for using same as anti-proliferative
|
|
FR2834990A1
(fr)
|
2002-01-18 |
2003-07-25 |
Pf Medicament |
Nouveaux anticorps anti-igf-ir et leurs applications
|
|
FR2834991B1
(fr)
|
2002-01-18 |
2004-12-31 |
Pf Medicament |
Nouveaux anticorps anti-igf-ir et leurs applications
|
|
ES2283759T3
(es)
|
2002-01-18 |
2007-11-01 |
Pierre Fabre Medicament |
Anticuerpos anti-igf-ir y sus aplicaciones.
|
|
US7241444B2
(en)
*
|
2002-01-18 |
2007-07-10 |
Pierre Fabre Medicament |
Anti-IGF-IR antibodies and uses thereof
|
|
FR2834900B1
(fr)
|
2002-01-18 |
2005-07-01 |
Pf Medicament |
Nouvelles compositions a activite anti-igf-ir et anti-egfr et leurs applications
|
|
US7553485B2
(en)
|
2002-01-18 |
2009-06-30 |
Pierre Fabre Medicament |
Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof
|
|
AU2003223661A1
(en)
|
2002-04-15 |
2003-11-03 |
Rigel Pharmaceuticals, Inc. |
Methods of assaying for cell cycle modulators
|
|
US7655397B2
(en)
*
|
2002-04-25 |
2010-02-02 |
The United States Of America As Represented By The Department Of Health And Human Services |
Selections of genes and methods of using the same for diagnosis and for targeting the therapy of select cancers
|
|
CA2483848C
(en)
|
2002-04-30 |
2012-08-21 |
Kyowa Hakko Kogyo Co., Ltd. |
Antibody against human insulin-like growth factor
|
|
US7485314B2
(en)
*
|
2002-05-06 |
2009-02-03 |
Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center |
Induction of antigen specific immunologic tolerance
|
|
NZ571508A
(en)
*
|
2002-05-24 |
2010-05-28 |
Schering Corp |
Neutralizing human anti-IGFR antibody
|
|
GB0212303D0
(en)
*
|
2002-05-28 |
2002-07-10 |
Isis Innovation |
Molecular targetting of IGF-1 receptor
|
|
US8034904B2
(en)
|
2002-06-14 |
2011-10-11 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
|
US7538195B2
(en)
*
|
2002-06-14 |
2009-05-26 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
|
US20040086511A1
(en)
*
|
2002-07-12 |
2004-05-06 |
The Johns Hopkins University |
Neuronal gene expression patterns
|
|
US20040142381A1
(en)
*
|
2002-07-31 |
2004-07-22 |
Hubbard Stevan R. |
Methods for designing IGF1 receptor modulators for therapeutics
|
|
US20040047835A1
(en)
*
|
2002-09-06 |
2004-03-11 |
Cell Therapeutics, Inc. |
Combinatorial drug therapy using polymer drug conjugates
|
|
US20030138430A1
(en)
*
|
2002-09-20 |
2003-07-24 |
Stimmel Julie Beth |
Pharmaceutical comprising an agent that blocks the cell cycle and an antibody
|
|
TW200501960A
(en)
|
2002-10-02 |
2005-01-16 |
Bristol Myers Squibb Co |
Synergistic kits and compositions for treating cancer
|
|
US20040102360A1
(en)
*
|
2002-10-30 |
2004-05-27 |
Barnett Stanley F. |
Combination therapy
|
|
AU2003287918A1
(en)
|
2002-12-20 |
2004-07-14 |
Enkam Pharmaceuticals A/S |
Method of modulation of interaction between receptor and ligand
|
|
KR20050109489A
(ko)
*
|
2003-02-13 |
2005-11-21 |
화이자 프로덕츠 인크. |
항-인슐린양 성장인자 i 수용체 항체의 용도
|
|
EP1603948A1
(en)
*
|
2003-03-14 |
2005-12-14 |
Pharmacia Corporation |
Antibodies to igf-i receptor for the treatment of cancers
|
|
ES2383014T3
(es)
|
2003-04-02 |
2012-06-15 |
F. Hoffmann-La Roche Ag |
Anticuerpos contra el factor I de crecimiento similar a insulina y usos de los mismos
|
|
US20050043233A1
(en)
|
2003-04-29 |
2005-02-24 |
Boehringer Ingelheim International Gmbh |
Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis
|
|
US7638605B2
(en)
*
|
2003-05-01 |
2009-12-29 |
ImClone, LLC |
Fully human antibodies directed against the human insulin-like growth factor-1 receptor
|
|
AR046071A1
(es)
*
|
2003-07-10 |
2005-11-23 |
Hoffmann La Roche |
Anticuerpos contra el receptor i del factor de crecimiento de tipo insulinico y los usos de los mismos
|
|
MXPA06001634A
(es)
*
|
2003-08-13 |
2006-04-28 |
Pfizer Prod Inc |
Anticuerpos humanos modificados igf-1r.
|
|
DE10348391B3
(de)
*
|
2003-10-17 |
2004-12-23 |
Beru Ag |
Verfahren zum Glühen einer Glühkerze für einen Dieselmotor
|
|
CN1938428A
(zh)
*
|
2003-11-12 |
2007-03-28 |
先灵公司 |
多基因表达的质粒系统
|
|
AR046639A1
(es)
*
|
2003-11-21 |
2005-12-14 |
Schering Corp |
Combinaciones terapeuticas de anticuerpo anti- igfr1
|
|
CA2564538A1
(en)
*
|
2004-04-22 |
2005-12-01 |
Oregon Health And Science University |
Compositions and methods for modulating signaling mediated by igf-1 receptor and erbb receptors
|
|
WO2005117980A1
(en)
|
2004-06-04 |
2005-12-15 |
Pfizer Products Inc. |
Method for treating abnormal cell growth
|
|
EP1802341A1
(en)
*
|
2004-07-16 |
2007-07-04 |
Pfizer Products Inc. |
Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody
|
|
JP2008512352A
(ja)
|
2004-07-17 |
2008-04-24 |
イムクローン システムズ インコーポレイティド |
新規な四価の二重特異性抗体
|
|
FR2873699B1
(fr)
|
2004-07-29 |
2009-08-21 |
Pierre Fabre Medicament Sa |
Nouveaux anticorps anti igf ir rt leurs utilisations
|
|
US20060205810A1
(en)
*
|
2004-11-24 |
2006-09-14 |
Schering Corporation |
Platinum therapeutic combinations
|
|
US20060233814A1
(en)
*
|
2005-04-15 |
2006-10-19 |
Immunogen Inc. |
Elimination of heterogeneous or mixed cell population in tumors
|
|
US20060233810A1
(en)
*
|
2005-04-15 |
2006-10-19 |
Yaolin Wang |
Methods and compositions for treating or preventing cancer
|
|
NZ564098A
(en)
*
|
2005-06-15 |
2010-04-30 |
Schering Corp |
Anti-IGF1R antibody formulations
|
|
US7612181B2
(en)
*
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
WO2007093008A1
(en)
|
2006-02-17 |
2007-08-23 |
Adelaide Research & Innovation Pty Ltd |
Antibodies to insulin-like growth factor i receptor
|
|
US20080112888A1
(en)
*
|
2006-06-30 |
2008-05-15 |
Schering Corporation |
Igfbp2 biomarker
|